CureVac BV (CVAC) is lower by Tuesday morning, with the stock falling -2.63% in pre-market trading to 45.45. CVAC's short-term technical score of 3 indicates that the stock has traded less bullishly over the last month than 97% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, CVAC ranks higher than 7% of stocks. CureVac BV has risen 16.50% over the past month, closing at $42.08 on November 2. During this period of time, the stock fell as low as $35.33 and as high as $47.76. CVAC has an average analyst recommendation of Sell. The company has an average price target of $53.00.
CVAC has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on CVAC!